Aslan Fred, President and CEO of Artiva Biotherapeutics ($ARTV), sold shares four times on the open market over the last year, for a total of $263 thousand. His most recent sale occurred on December 15, 2025. With no purchases recorded, his sales rank 7,845th out of 11,678 insiders in the database, well below the average of $8.6 million and 6 transactions per insider.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | F | Common Stock | 14600 | $4.00 | 1,562,198.0000 | 24,544,904 | 0.93% | 0.06% |
| Feb. 15, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | A | Common Stock | 366850 | $0.00 | 1,576,798.0000 | 24,544,904 | 30.32% | 1.49% |
| Dec. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | S | Common Stock | 3187 | $6.00 | 1,209,948.0000 | 24,544,904 | 0.26% | 0.01% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | A | Common Stock | 869136 | $0.00 | 1,213,135.0000 | 24,544,904 | 252.66% | 3.54% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 100577 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.41% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 51463 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.21% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 257319 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 1.05% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 26450 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.11% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 113999 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.46% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | D | Employee Stock Option (Right to Buy) | 319331 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 1.30% |
| Nov. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | F | Common Stock | 6347 | $3.25 | 350,374.0000 | 24,544,904 | 1.78% | 0.03% |
| Nov. 17, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | S | Common Stock | 6375 | $3.38 | 343,999.0000 | 24,544,904 | 1.82% | 0.03% |
| Oct. 17, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | S | Common Stock | 25500 | $6.00 | 356,721.0000 | 24,363,119 | 6.67% | 0.10% |
| Aug. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | F | Common Stock | 4472 | $2.75 | 382,221.0000 | 24,363,119 | 1.16% | 0.02% |
| Aug. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | S | Common Stock | 25500 | $2.73 | 386,693.0000 | 24,363,119 | 6.19% | 0.10% |
| May 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | F | Common Stock | 4472 | $2.13 | 412,193.0000 | 24,363,119 | 1.07% | 0.02% |
| March 5, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | A | Common Stock | 200000 | $0.00 | 416,665.0000 | 0 | 92.31% | 0.00% |
| July 18, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | A | Employee Stock Option (Right to Buy) | 343811 | $0.00 | 343,811.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | Aslan Fred | President and CEO | A | Common Stock | 228905 | $0.00 | 228,905.0000 | 0 | 9999.99% | 0.00% |